Clinical Research Directory

Inclusion Criteria: 1. Age ≥ 18 years; 2. Subjects with refractory/relapsed multiple myeloma who meet product indication criteria and have received commercialized zevor-cel infusion. 3. Voluntary participation in this study and willingness to sign the informed consent form, for subjects incapable to provide consent, informed consent must be obtained from their legally acceptable guardians. Exclusion Criteria: 1\. There were no specific exclusion criteria for this study。